Given the prevailing need for diagnostic, prognostic, and predictive tools in the treatment of BTC, and the emerging evidence on an involvement of PITX2 in various cancers, this study was designed to investigate the DNA methylation status of the promoter regions of the PITX2 gene loci and the intragenic region of lncRNA PANCR in BTC. The gene discussed is PITX2; the disease is cancer.